Open AccessP932: ON‐DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G‐CSF FOR HEMATOPOIETIC STEM‐CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY
Author(s) -
Mina R.,
Bonello F.,
Fazio F.,
Saccardi R.,
Bongarzoni V.,
Marchesi F.,
Bertuglia G.,
Curci P.,
Lemoli R. M.,
Ballanti S.,
Dentamaro T.,
Benevolo G.,
Capra A.,
Floris R.,
Tosi P.,
Olivieri A.,
RotaScalabrini D.,
Cangialosi C.,
Cavo M.,
Corradini P.,
Milone G.,
Boccadoro M.,
Larocca A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846596.07227.f0
Subject(s) - plerixafor , medicine , lenalidomide , multiple myeloma , melphalan , cyclophosphamide , granulocyte colony stimulating factor , cd34 , stem cell , clinical endpoint , cxcr4 , bortezomib , oncology , surgery , chemotherapy , clinical trial , biology , chemokine , receptor , genetics